CONFERENCES

      Fraunhofer Seminar

      This is an annual seminar that focuses on technology transfer and innovation management, with topics ranging from intellectual property to market analysis. The seminar is aimed at researchers, industry professionals, and policymakers involved in the development and commercialization of technology, and provides a forum for sharing knowledge and collaborating on new approaches to technology transfer.

      Models of Lung Disease 2023

      Date

      Jun 22, 2023 - Jun 23, 2023

      Location

      Hannover, Germany

      The 21st Fraunhofer Seminar "Models of Lung Disease" expects around 120 attendees and aims to discuss the ideas on developing new cures against lung diseases, gain new perspectives, and expand network.

      Models of Lung Disease 2020

      Date

      Feb 06, 2020 - Feb 07, 2020

      Location

      Hannover, Germany

      Bringing over 120 participants, this workshop organized by Fraunhofer ITEM in cooperation with the German Center for Lung Research (DZL), provides a platform for intense discussions between industry and academia about predictive disease models and translational lung research.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.